← Back

Mandrake Bio

Bengaluru, India

pre-seed$1.9M raisedFreshly fundeddeeptechbiotechhealthtech

Total Raised

$1.9M

Stage

pre-seed

Location

Bengaluru, India

Founded

2025

Team size

1-10

Links

About Mandrake Bio

Bengaluru-based biotechnology startup using artificial intelligence to design new gene-editing enzymes for agriculture and healthcare.

What sets it apart

They combine mobile genetic elements with AI-powered protein engineering to create de novo gene editors from first principles, unlike competitors relying on natural enzyme variants.

Sectors

deeptechbiotechhealthtechclimate techagritechAI

Business

ModelSaaS

CustomerAgriculture companies, healthcare/pharma firms, longevity research institutions, and climate resilience organizations

Notable

  • Won a protein binder design competition with 12,000+ designs and only 1 strong binder as a weekend side-project
  • Funded by some of India's top VCs and angels
  • Building foundational AI stack for biology with large-scale data engines and generative design systems

Backing funds on Raise

Funding rounds

16 Jul 2026

Led by Activate, Antler

With Spectrum Impact, DeVC

Source ↗

Explore the market

FAQ

What does Mandrake Bio do?

Bengaluru-based biotechnology startup using artificial intelligence to design new gene-editing enzymes for agriculture and healthcare.

Where is Mandrake Bio based?

Mandrake Bio is based in Bengaluru, India, founded in 2025.

How much has Mandrake Bio raised?

Mandrake Bio has raised $1.9M in tracked funding and is currently at the pre-seed stage.

Who has invested in Mandrake Bio?

Investors in Mandrake Bio include India's best VCs and Angels.